======= FADS2 ======= == Gene Information == * **Official Symbol**: FADS2 * **Official Name**: fatty acid desaturase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9415|9415]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95864|O95864]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FADS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FADS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606149|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the first and rate limiting step in this pathway which is the desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma- linoleic acid (GLA) (18:3n-6) and stearidonic acid (18:4n-3) respectively and other desaturation steps. Highly unsaturated fatty acids (HUFA) play pivotal roles in many biological functions. It catalizes as well the introduction of a cis double bond in palmitate to produce the mono-unsaturated fatty acid sapienate, the most abundant fatty acid in sebum. {ECO:0000269|PubMed:12713571, ECO:0000269|PubMed:9867867}. |Cyt-b5| |FA desaturase| |linoleoyl-CoA desaturase activity| |stearoyl-CoA 9-desaturase activity| |alpha-linolenic acid metabolic process| |linoleic acid metabolic process| |unsaturated fatty acid biosynthetic process| |unsaturated fatty acid metabolic process| |long-chain fatty acid metabolic process| |fatty acid biosynthetic process| |monocarboxylic acid biosynthetic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |fatty acid metabolic process| |drug metabolic process| |monocarboxylic acid metabolic process| |lipid biosynthetic process| |small molecule biosynthetic process| |carboxylic acid metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |integral component of plasma membrane| |small molecule metabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|1.77| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|1.78| |[[:results:exp121|Golgicide-A 2μM R03 exp121]]|2.08| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|2.65| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|3.09| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|3.25| |[[:results:exp436|Dynasore 7μM R08 exp436]]|3.35| |[[:results:exp180|Dynasore 10μM R04 exp180]]|4.08| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|5.01| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3122 * **Expression level (log2 read counts)**: 8.29 {{:chemogenomics:nalm6 dist.png?nolink |}}